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Breast cancer is the leading cause of cancer death in women worldwide. Its surgical 
approach has become less and less mutilating in the last decades. However, the overall 
number of breast reconstructions has significantly increased lately. Nowadays, breast 
reconstruction should be individualized at its best, first of all taking into consideration 
not only the oncological aspects of the tumor, neo-/adjuvant treatment, and genetic 
predisposition, but also its timing (immediate versus delayed breast reconstruction), as 
well as the patient’s condition and wish. This article gives an overview over the various 
possibilities of breast reconstruction, including implant- and expander-based recon-
struction, flap-based reconstruction (vascularized autologous tissue), the combination 
of implant and flap, reconstruction using non-vascularized autologous fat, as well as 
refinement surgery after breast reconstruction.
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iNTRODUCTiON
Breast cancer is the leading cause of cancer death among women worldwide with ~1.7 million new 
diagnoses and 521.900 deaths in 2012 (1). One important modality of breast cancer therapy is surgi-
cal treatment, which has become increasingly less mutilating over the last century.
William Halsted introduced radical mastectomy including resection of the breast and its 
underlying pectoralis major muscle in order to cure all stages of breast cancer at the end of the 
nineteenth century (2). Approximately 40 years later, Patey described a less radical modified type 
of mastectomy with preservation of the pectoralis major muscle yielding comparable local control 
and overall survival compared to Halsted (3). In 1985, Fisher et al. introduced the concept of breast 
conserving therapy (BCT), demonstrating that lumpectomy – by that time regarded as segmental 
 mastectomy  –  followed by adjuvant radiotherapy of the remnant breast in patients with stage I 
and II breast cancer was indeed associated with an increased local recurrence rate, yet resulted in 
equal survival rates compared to mastectomy (4). Oncoplastic breast surgery, i.e., reshaping of the 
breast after local tumor resection, has shown to allow larger tumor excision, yet conserving large 
parts of the breast, maintaining shape (5) and resulting in improved quality of life and self-esteem 
(6). While surgical breast cancer treatment decreased in radicalness and invasiveness, breast cancer 
guidelines were defined, breast cancer screening programs were initiated, and breast centers offering 
an interdisciplinary and comprehensive therapeutical approach for breast cancer were established. 
This resulted in an increased detection and treatment of predominantly early breast cancers with 
improved survival rates and consequently superior esthetic outcome. Nowadays, BCT is a safe treat-
ment for most women with early-stage breast cancers and can be safely applied in 70–80% of the 
cases requiring surgical tumor removal (7). Though, the primary goal of BCT is to preserve shape 
FiGURe 1 | The 43- and 63-year-old patients after modified radical 
mastectomy of the left breast (A), respectively, of both breasts (B). 
Indication for autologous reconstruction with a microvascular flap, particularly 
if skin and fat excess is available and adjuvant radiotherapy has been 
performed.
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and, to a lesser extent, size of the breast in order to best match 
the contralateral breast. Thereby, one should take into account 
that postoperative radiotherapy may result in some extent of 
tissue shrinkage (8). Although decreasing in number over the 
last two decades, the rate of mastectomy has again increased 
lately due to the detection of multifocal tumors, tumors with 
an extended in  situ proportion that is difficult to delimit and 
due to an unfavorable breast-to-tumor size ratio in rather thin 
patients with small-to-intermediate sized breasts. Furthermore, 
the awareness of the disease itself in the female population and 
the relatively frequent detection of a genetic predisposition to 
breast cancer (i.e., BRCA-1, BRCA-2, p53) have confirmed this 
trend toward an increased rate of mastectomy, be it curative or 
prophylactic (9).
Although BCT remains the absolute gold standard for surgical 
breast cancer treatment, many women must or wish to undergo 
mastectomy. Consequently, reconstruction of the breast must 
be offered, particularly in young patients. This article provides 
an overview of various reconstruction techniques of the female 
breast after both, breast cancer-related and prophylactic mastec-
tomy. This article does not cover partial breast reconstruction 
after extensive breast conservative therapy.
MASTeCTOMY
Mastectomy aims at resecting as much breast tissue as possible, 
knowing that glandular tissue will almost always remain in the 
region of the inframammary fold (10). Nowadays, basically 
two ways of mastectomy are performed, including skin-sparing 
mastectomy and total ablation of the breast. The latter consists 
of complete removal of both, breast skin and glandular breast 
tissue (Figure  1), whereas skin-sparing mastectomy preserves 
as much of the breast’s skin envelope as possible, including the 
areola and the nipple (skin-sparing mastectomy, areola-sparing 
mastectomy, nipple-sparing mastectomy, skin-reducing mastec-
tomy) and the inframammary fold. Furthermore, biopsy scars 
and skin overlying a tumor or even infiltrated by the tumor 
are excised in order to reduce the risk of local recurrence (11). 
Provided that the oncological indication is correct, skin-sparing 
mastectomy has been associated with equal oncological local 
safety and improved esthetic outcome compared to modified 
radical mastectomy (10). Furthermore, the need for secondary 
surgery to adjust the contralateral breast in order to achieve sym-
metry is reduced after skin-sparing mastectomy, particularly if 
autologous reconstruction with flaps is used (12).
Lately, prophylactic bilateral mastectomy has to be offered 
more and more frequently due to the increased detection of 
patients carrying a genetic mutation or predisposition to develop 
breast cancer (e.g., BRCA-1, BRCA-2, p53). Understandably, these 
women have high demands to the esthetic outcome that can be 
overcome with nipple-sparing mastectomy being accepted as the 
gold standard in patients with prophylactic mastectomies (13).
Noteworthy, skin- and nipple-sparing mastectomies are asso-
ciated with a high rate of ischemia-related wound breakdown 
and necrosis of up to 54%, which is a consequence of a critically 
impaired blood supply of the distant areas of the often very thin 
skin flap. Meanwhile, various approaches have been described to 
decrease ischemia-associated complications of the mastectomy 
skin flap, including surgical skin reduction of the mastectomy flap, 
temporary insertion of an expandable implant, and local applica-
tion of vasodilators. Interestingly, first clinical data have shown 
that local heat preconditioning was able to safely and significantly 
reduce ischemia-related mastectomy skin flap complications in 
patients with skin-sparing mastectomy and immediate breast 
reconstruction (14).
ReCONSTRUCTiON TeCHNiQUeS  
OF THe BReAST
Breast reconstruction depends primarily on the type of 
mastectomy and may be classified in various ways, such as 
reconstruction type and reconstruction time point. The latter 
includes delayed breast reconstruction (DBR; secondary breast 
reconstruction) and immediate breast reconstruction during the 
same surgery (IBR; primary breast reconstruction). IBR has the 
advantage of reducing the total number of surgical procedures. 
Since breast reconstruction per se represents an additional pro-
cedure to mastectomy, the potential surgery-related complica-
tions of both mastectomy and reconstruction accumulate due to 
prolonged surgery time, particularly if mastectomy is performed 
using a skin reducing or skin-sparing approach (hematoma due 
to bleeding of the mastectomy flap, ischemic complications of 
the mastectomy flap, infection, etc.), respectively, reconstruction 
is performed with implants. This has to be taken into consid-
eration in order not to postpone adjuvant therapy, i.e., foremost 
chemotherapy, to the disadvantage of the patient (15). Despite 
very effective diagnostic work-up of breast cancer and highly 
standardized neo- and adjuvant treatment regimes, IBR bears 
the risk that unforeseen adjuvant radiotherapy may compromise 
the final result of the reconstructed breast, such as capsular 
contracture in implant-based reconstructions, respectively flap 
shrinkage in autologous reconstructions. Therefore, many sur-
geons may tend to a DBR when using free (microvascular) flaps 
in cases of an invasive tumor requiring adjuvant radiotherapy. 
In order not to lose the skin envelope after skin-sparing mas-
tectomy, one can place a spacer until completion of adjuvant 
FiGURe 2 | A 58-year-old patient before skin-sparing mastectomy for 
multifocal cancer of the left breast (A). Four years after primary 
reconstruction of the left breast using an implant in a subpectoral plane to 
cover the upper half of the implant and a resorbable mesh to prevent 
cranialization of the partially detached pectoralis major muscle, as well as 
reconstruction of the nipple–areolar complex (star flap for the nipple and 
tatoo of the nipple and neo-areola). Note the almost symmetric size and 
contour of both breasts (B).
FiGURe 3 | Typical donor site for abdominal flap-based breast 
reconstruction. A 57-year-old patient before (A) and 4 years after  
(B) harvesting a microvascular deep inferior epigastric perforator (DIEP) artery 
flap from the abdominal region. Note the adipocutaneous excess cranially 
and distally of the umbilicus, the almost invisible scar at the umbilicus and the 
suprapubic region, as well as the significantly improved abdominal contour 
[profile view (A,B)]. The reconstructed breast of this patient is shown in 
Figure 6.
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therapy. Nonetheless, IBR is advantageously associated with a 
reduced recovery time, a better esthetic outcome, an improved 
quality of life, and, finally, lower surgery- and recovery-related 
costs (16–18).
Nowadays, the seek for bilateral prophylactic mastectomy 
particularly in women with a genetic predisposition for breast 
cancer (e.g. BRCA-1, BRCA-2, p53) increases and accordingly 
represents an ideal indication for IBR of any type, knowing that 
neither adjuvant chemotherapy nor adjuvant radiotherapy will 
be required (19).
Generally, three different approaches of breast reconstruction 
may be considered: (1) breast reconstruction using implants 
and skin expanders, (2) breast reconstruction using flaps (vas-
cularized autologous tissue), and (3) breast reconstruction using 
non-vascularized lipoaspirate autologous fat. In the following, 
the different approaches will be briefly highlighted, including the 
advantages and disadvantages of each approach.
Breast Reconstruction Using implants and 
Skin expanders
The use of implants and skin expanders is not only the oldest way 
to reconstruct a breast but also the quickest and presumably easi-
est method of breast reconstruction. Accordingly, implant-based 
breast reconstruction is by far the most often used technique 
worldwide (9, 20). The prerequisite for implant-based breast 
reconstruction is an adequate skin envelope that allows covering 
the implant that is usually introduced in a submuscular plane 
detaching the medial insertions of the pectoralis major muscle 
from the ribs.
Implant-Based Breast Reconstruction
Basically, the first “implant”-based breast reconstruction was 
performed 1895 by Vincenz Czerny, who used a patient’s lipoma 
from the lumbar region to reconstruct a post-surgical asymmetry 
after tumor removal (21).
Cronin and Gerow fathered the modern era of silicone gel-
filled breast implants and so allowed DBR (22, 23). Nowadays, 
fifth generation silicone gel-filled breast implants that contain a 
highly viscous and more or less form-stable gel are usually used. 
The implants are available in both, round and anatomical shape 
and vary in width, height, and projection (profile). Implant-based 
breast reconstruction is used in women who do not want any 
additional scars (flap harvesting) (Figure 2) or do not have any 
adequate flap donor site (e.g., lean patient, pre-existing scars, and 
medical conditions).
Implant-based breast reconstructions prone to develop 
implant-related local complications during the subsequent 
10 years with a risk for a reoperation of 70% (24). Approximately 
25 and 35% of the patients are being diagnosed with severe capsu-
lar contracture and, respectively, implant rupture (25). This high 
complication rate results from the thin skin envelope remaining 
after mastectomy, which does not provide any robust coverage 
of the implant. This complication rate does neither consider 
breast shape deformity and asymmetry in the context of mild to 
moderate capsular contracture nor does it consider an even worse 
outcome in implant-based breast reconstruction with irradiated 
skin. De facto, breast reconstruction using implants may yield 
very nice long-term results that suffice many patients, yet the 
implant will always remain more or less fixed to the thoracic wall 
and consequently the breast maintains a unique shape, indepen-
dently from the patient’s posture. Finally, implant-based breast 
reconstruction will not allow recreating a naturally shaped ptotic 
breast in most patients, and therefore often requires adaptive 
surgery of the contralateral breast to achieve symmetry. Though, 
implant-based breast reconstruction prevents from “collateral 
damage,” such as scars, contour deformity, and muscular weak-
ness, as it might be seen after flap harvesting for flap-based breast 
reconstruction (Figure 3).
FiGURe 4 | Typical donor site for myocutaneous latissimus dorsi 
flap-based breast reconstruction. A 36-year-old patient before (A) and 
2 years after secondary reconstruction of the left breast using a pedicled 
myocutaneous latissimus dorsi flap (B). The skin island is harvested along the 
posterior axillary line. Note the well concealed scar (usually in the bra-line) 
that does not interfere with the back of the patient, yet skin and muscle 
harvesting result in a slight contour deformity of the periscapular region 
[arrow; (B)]. The reconstructed breast of this patient is shown in Figure 5.
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Expander-Based Breast Reconstruction
The technique of tissue expansion has first been described by 
Radovan in 1976, and since then, it has been used on a regular 
base in order to recreate the amount of lost skin after mastec-
tomy through stepwise expansion of the remaining chest skin 
(26). Ideally, the contralateral breast volume should not exceed 
a volume of 300–400  g. Typically, patients with pre-expansion 
of the breast skin undergo secondary breast reconstruction 
with implants. In selected cases, especially in young and skinny 
patients with insufficient skin laxity, yet enough adipose tissue 
to reconstruct a breast mound of ~300–350  g, one might pre-
expand the breast skin after mastectomy in order to substitute the 
expander with an autologous flap.
The main drawback of skin expansion are the frequent out-
patient visits to gradually fill the expander, the need for an addi-
tional procedure (i.e., expander removal for permanent implant 
or flap) and the relatively high rate of complications, such as 
infection, capsular contracture, and skin perforation (27).
Alternatively, skin expanders can be used as “spacers” after 
skin-sparing mastectomy in order not to lose the skin pocket. 
This approach is particularly helpful in patients who are sure to 
get adjuvant radiotherapy of the skin and/or the thoracic wall. 
Indeed, postoperative radiotherapy will not significantly increase 
the rate of flap-related complications (28). Yet, IBR is more and 
more frequently performed using microvascular (free) flaps 
despite postoperative radiotherapy. However, we currently do not 
know at what extent the flap will indurate and shrink at long-term 
follow-up.
Breast Reconstruction with Acellular Dermis
The use of acellular dermal matrices in implant- and expander-
based breast reconstruction has lately become more and more 
popular. Matrices are usually of human, porcine, or bovine 
origin. They have shown to improve esthetic outcome and reduce 
implant-related morbidity (29), such as a decreased rate of cap-
sular contracture (30–32), an improved tolerance to radiotherapy, 
and a more natural anatomical reconstruction of the inframam-
mary fold and final breast contour (33).
Nahabedian demonstrated a high safety and excellent results 
using acellular dermis in a 12-year follow-up, even in the setting 
of reconstruction after infection or radiotherapy. However, other 
authors reported several matrix-related complications, such as 
hematoma, infection, and foremost late seromas (29). The use 
of matrices is again and again associated with a rather high rate 
of early complications. Lardi et al. have demonstrated that these 
complications were mostly related to patient characteristics and 
a learning curve, highlighting the importance of patient selection 
and technical principles (34).
Breast Reconstruction Using Flaps 
(vascularized Autologous Tissue)
The myocutaneous flaps that are being used for breast reconstruc-
tion have a long history, although the techniques of today are much 
more sophisticated than those of the past. Louis Ombredanne 
from France was the first to use a pedicled pectoralis muscle flap 
for IBR in 1906. Differently as his colleagues, Ombredanne was 
the first who wittingly tried to reconstruct not only the skin defect 
after mastectomy but also the breast mound that was considered 
at that time a “luxury” procedure with limited indications (35). 
Almost simultaneously, Tanzani from Italy used the pedicled 
myocutaneous latissimus dorsi flap to close mastectomy defects 
for the first time.
Flap surgery for breast reconstruction has been performed on 
a regular base, since the mid 70s, initially using both, tubed flaps 
from the abdomen (36) and thoraco-epigastric, necessitating 
several surgical stages (23). The initial attempts were still not able 
to really reconstruct the breast mound and therefore primarily 
aimed at resurfacing the thoracic wall’s defects after radical 
mastectomy. Finally, it was the introduction of the myocutaneous 
latissimus dorsi flap with its overlying skin island, as described by 
Tanzani 70 years earlier, which allowed to restore mastectomy-
induced skin loss and to a lesser extent also volume loss (37–39).
Almost at the same time, Bostwick described the combined use 
of the myocutaneous latissimus dorsi flap and a silicone implant 
to consistently provide adequate skin coverage, respectively, to 
restore the breast mound in postmastectomy reconstruction (40).
The advantage of the latissimus dorsi flap is its rather consistent 
anatomy and therefore easy flap harvest. However, flap transfer 
from the back can be associated with highly visible scars, contour 
deformity of the thorax ventrally and the back dorsally as well as 
animation of the skin/muscle-implant complex of the pectoralis 
major respectively latissimus dorsi muscle due to innervation 
of the latter one (Figure  4). Otherwise, the muscle undergoes 
atrophy of 50–75% of its volume unconditionally, almost always 
requiring an implant to restore volume, unless the patient is 
rather thin (Figure 5).
Since this reconstructive approach combines two basic tech-
niques of reconstructive surgery, i.e., skin replacement with the 
flap and volume restoration with the implant, the patients are 
subject to an accumulation of the two technique’s morbidities, 
which might be significant, particularly years after reconstruc-
tion. Tarantino et  al. demonstrated that 57% of the patients 
treated with a latissimus dorsi flap and implants had revisional 
surgery for implant replacement or implant removal after a mean 
follow-up of 10 years, and concluded that the indication for this 
FiGURe 5 | A 36-year-old patient 3 years after modified radical 
mastectomy of the left breast and adjuvant radio-chemotherapy. Note 
the oblique scar and rather large skin envelope in a thin patient (A). Two 
years after secondary reconstruction of the left breast using a pedicled 
myocutaneous latissimus dorsi flap without implant and reconstruction of the 
nipple–areolar complex (star flap for the nipple and tatoo of the nipple and 
neo-areola). Note the almost symmetric neckline and the slight volume loss of 
the lower pole of the breast resulting in contour deformity (B). The donor site 
of this patient is shown in Figure 4.
January 2016 | Volume 2 | Article 715
Schmauss et al. Breast Reconstruction after Mastectomy
Frontiers in Surgery | www.frontiersin.org
procedure should be restricted to patients who do not qualify for 
either implant-based or flap-based breast reconstruction (41).
In 1987, Hokin and Silfverskiold described the use of an 
extended latissimus dorsi flap to avoid the use of an implant. The 
flap’s volume was significantly increased by dissecting the subcu-
taneous fat surrounding the skin island (42). Unfortunately, donor 
site morbidity increased dramatically, including prolonged seroma 
respectively wound dehiscence rate, and contour deformity (43).
The true progress in flap-based breast reconstruction occurred 
in 1982 when Hartrampf and colleagues used the cranially pedi-
cled rectus abdominis muscle flap with a horizontally oriented 
adipocutaneous skin island (TRAM flap) supplied by the deep 
superior epigastric artery to anatomically reconstruct volume and 
shape of the breast in one single stage without using implants (44).
Although this procedure was able to both, restore the ablated 
breast and improve abdominal contour despite scars at the 
umbilicus and the waistline, following significant disadvantages 
have to be taken into consideration: a high tissue-to-blood supply 
ratio of the flap, protracted recovery of the patient and abdominal 
wall weakness, including bulging and herniation due to sacrifice 
of the rectus abdominis muscle and large part of its anterior fascia.
To overcome these drawbacks of the donor site of the pedicled 
TRAM flap, Arnez and colleagues and Grotting et  al. popular-
ized the free TRAM flap, i.e., the microvascular anastomosis of 
at least one artery and one vein of the flap to recipient vessels. In 
doing so, the authors were able to demonstrate a more limited 
harvest of the rectus abdominis muscle, a safer transfer due to 
improved perfusion originating from the larger caudal pedicle 
(deep inferior epigastric artery instead of deep superior epigastric 
artery), and an improved medial breast contour due to the lack of 
tunneling of the flap’s cranial pedicle (45, 46). Further refinement 
of the surgical technique over time aimed at decreasing as much 
as possible the weakening of the abdominal wall despite transfer-
ring most of the abdominal skin and its underlying subcutaneous 
tissue, including muscle sparing free TRAM flap (47), fascia 
sparing free TRAM flap (48), to finally achieve complete muscle 
preservation. The latter was obtained by dissecting the vascular 
pedicle of the adipocutaneous abdominal flap perforating the 
rectus abdominis muscle (deep inferior epigastric perforator 
(DIEP) artery flap) as described by Allen and Treece (49) and 
Blondeel and Boeckx (50) (Figure  6). The concept of this so-
called “perforator flap” or DIEP flap has somehow revolutionized 
breast reconstruction by maximizing the amount of safe tissue 
transfer, yet minimizing donor site morbidity. Abdominal tissue 
is very suitable for breast reconstruction, since many patients 
have a certain abdominal excess of skin and fat. Consequently, 
autologous breast reconstruction using a DIEP flap nowadays 
represents the gold standard. In case of concomitant chronic 
lymphedema of the arm after sentinel lymph node biopsy, axillary 
lymph node dissection and or/radiotherapy of the lymph node 
basins, one can surgically address this problem using lympha-
ticovenous anastomosis or microvascular lymph node transfer. 
The latter can easily be combined with a DIEP flap, since the flap 
mostly consists of the lymph nodes in the groin area lateral to the 
femoral vessels and depends on the pedicle originating from the 
superficial inferior epigastric vessels (51). Given that not every 
women is suitable for breast reconstruction using abdominal skin 
and fat, many more donor sites were described in the following 
years, aiming at harvesting the most suitable microvascular flap 
to best personalize breast reconstruction. This included, among 
others, the superior gluteal artery perforator (sGAP) flap (52), 
the inferior gluteal artery perforator (iGAP) flap (53) from the 
gluteal region, the fasciocutaneous infragluteal (FCI) flap (54), 
the profunda femoral artery perforator (PAP) flap (55) from the 
infragluteal region, and the transverse myocutaneous gracilis 
(TMG) flap from the inner thigh region (56).
FiGURe 6 | A 57-year-old patient 2 years after modified radical 
mastectomy of the left breast and adjuvant radio-chemotherapy. Note 
the lack of skin and volume (A). Four years after secondary reconstruction of 
the left breast using a microvascular deep inferior epigastric perforator (DIEP) 
artery flap from the abdominal region and reconstruction of the nipple–areolar 
complex (star flap for the nipple and tatoo of the nipple and neo-areola). Note 
the almost symmetric size and contour of both breasts without corrective 
surgery of the non operated contralateral breast (B). The donor site of this 
patient is shown in Figure 3.
FiGURe 7 | A 58-year-old patient 2 years after modified radical 
mastectomy of the left breast, adjuvant radio-chemotherapy, and 
secondary expander–implant-based reconstruction. The patient 
developed a capsular contracture Baker grade IV with a hard, deformed, and 
painful breast fixed to the thoracic wall (A). One year after implant removal, 
radical capsulectomy and secondary reconstruction of the left breast using a 
microvascular deep inferior epigastric perforator (DIEP) artery flap from the 
abdominal region. Note the contour deformity in the neckline and upper pole 
region of the breast resulting from partial fat necrosis of the flap (B). 
Approximately 1.5 years after refinement of the contour deformity using two 
sessions of autologous fat grafting. Note the almost symmetric size and 
contour of both breasts (C).
TABLe 1 | Advantages and disadvantages of implant-based versus 







Duration of surgery (h) 1–2 4–6
Infrastructural effort Low Higha
Surgical complexity Low High
Donor site None Depending on flapb 
(abdominal, thigh, 
gluteal, dorsal region)






Higher (due to 
capsular contracture)
Lower
Long-term reoperation rate More likely Less likely
Patient satisfaction Short-term Long-term
aMicroscope, specific instruments, trained personnel (nurses in OR).
bDiscomfort, pain, scars, abdominal bulging, hernia, asymmetry, and contour deformity.
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Nowadays, the internal mammary artery and its concomitant 
vein are predominantly used as the recipient vessels. Alternatively, 
the arterial branches originating from the subscapular artery 
(e.g., thoracodorsal artery, circumflex scapulae artery) or sternal 
perforators arising through the pectoral muscle are used.
Although breast reconstruction using autologous flap tissue 
allows a natural and durable result, flap harvest will cause a 
“collateral damage” at the flap’s donor site, including potential 
surgery-related complications, scars, contour deformity, and func-
tional impairment. Furthermore, microvascular flap-based breast 
reconstruction is not only technically more demanding, but also 
requires more infrastructures within a breast reconstruction unit, 
as compared to implant-based breast reconstruction (Table 1).
Fat Graft-Based Breast Reconstruction 
Using Non-vascularized Lipoaspirate Fat
Autologous fat grafting (AFG; lipografting, lipofilling) describes 
the harvesting of the patient’s fat using liposuction followed by 
its reinjection into the tissue to be corrected or augmented. Fat 
grafting to the breast is more than 100 years old since Holländer 
corrected a retracted scar after mastectomy by injecting parceled 
fat into the scar (57). AFG to the breast has become a popular 
tool over the last 20  years, both in esthetic and reconstructive 
surgery. Regarding the breast, AFG has proven to be particularly 
effective to correct post-surgical irregularities, such as contour 
deformities and volume asymmetries after BCT, “rippling” after 
implant-based reconstruction and improvement of the transition 
zone between flap and skin in the neckline (58–60), as well as the 
preparation of the postmastectomy irradiated chest wall prior to 
implant placement (61). In selected cases, de novo reconstruc-
tion of the breast by means of AFG has shown very promising 
results. The patient must have several donor sites equipped with 
fat, because the reconstructive procedure usually takes four to 
six stages of fat grafting, each separated by 3 months at least (62). 
Irradiated skin does almost preclude this approach, since injected 
fat is not engrafted as desired (63).
Autologous fat grafting is a “natural” filler, and unlike syn-
thetic fillers will neither induce any foreign body reaction nor 
be resorbed completely. Today, harvesting of the fat is discussed, 
among others, with regard to composition of the infiltration 
solution, to diameter and shape of the harvesting cannula and to 
suction forces. In order to be structural, injection of the fat should 
be performed in small aliquots using blunt cannulas in multiple 
directions and multiple layers. This multi-planar approach maxi-
mizes the fat-to-tissue contact, thereby the exposition of non-
vascularized fat to vascularized host tissue (64). Consensus exists 
on the fact that fat may not be injected into the glandular tissue of 
the breast. Commonly, 60–70% of the injected fat is engrafted to 
the host tissue. Fat necrosis and oil cysts are common complica-
tions after AFG and occur in ~5% (65). Unfortunately, necrosis of 
the grafted fat might also be associated with microcalcifications, 
which sometimes may be difficult to distinguish from malignant 
breast cancer-associated microcalcifications (66). Presumably, the 
radiologist is an expert, fat grafting-induced microcalcifications 
do no impact on the radiological follow-up (67). Yet, this fact 
may unsettle the patient who has to appear for regular follow-up 
imaging and eventually undergo diagnostic biopsy to exclude 
malignancy.
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Currently, fat grafting to the breast is controversially discussed, 
particularly in the presence of remaining glandular breast tissue, 
as, for example, after BCT. Grafted fat that naturally contains 
progenitor and stem cells has lately been associated with breast 
cancer progression and metastasic spread in an experimental set-
ting (68, 69). Despite the lack of prospective follow-up studies, fat 
grafting to reconstruct or to refine a breast after mastectomy and/
or after breast reconstruction – BCT not included – is nowadays 
considered safe (70–72).
ReFiNeMeNT SURGeRY AFTeR  
BReAST ReCONSTRUCTiON
After breast reconstruction, particularly if breast reconstruction 
is performed unilaterally, refinement surgery may be necessary to 
reach symmetry of the breasts with regard to shape, contour, and 
size. The procedures usually consist of mastopexy, breast reduc-
tion, or breast augmentation using implants. Nowadays, AFG 
is often used to correct small volume asymmetries and contour 
deformities. The latter may occur after implant-based breast 
reconstruction (e.g., “rippling”), as well as after flap-based breast 
reconstruction (e.g., partial fat necrosis of the flap, transition zone 
between flap and neckline cranially). Refinement surgery is usually 
offered not earlier than 3 months after reconstruction or 6 months 
after completion of adjuvant radiotherapy. Fat grafting has often 
to be repeated. Its engraftment rate is ~60% (~40% fat resorption) 
(Figure 7). Last but not least, mastectomy is associated with the 
loss of the nipple–areolar complex (except for nipple-sparing 
mastectomy), requiring its reconstruction. Many techniques of 
reconstruction are available, including local flaps of the adjacent 
skin, skin grafts, tattoo, and a combination of all techniques.
CONCLUSiON
Breast cancer is the leading cause of cancer death in women. Its 
surgical approach has become less and less mutilating, allowing for 
70–80% of the operated cases to undergo (BCT) that has proven to 
be as safe as mastectomy with regard to overall survival. In other 
words, 20–30% of the operated women are subjected to mastec-
tomy. Since ~25 years, the skin-sparing mastectomy approach is 
an alternative to ablation of the breast allowing for better esthetic 
results due to preservation of the breast’s skin envelope, yet from an 
oncological point of view as safe as mastectomy. Other than mas-
tectomy, skin-sparing mastectomy needs immediate reconstruc-
tion in order not to lose the skin envelope that unreconstructed 
will inevitably retract and shrink to the level of the thoracic wall. 
Nowadays, breast reconstruction should be personalized at its best, 
first of all taking into consideration not only the oncological aspects 
of the tumor, neo-/adjuvant treatment and genetic predisposition, 
but also its timing (IBR versus DBR), as well as the patient’s condi-
tion and wish. Despite this complex decision-making including 
many aspects, the overall number of breast reconstruction has 
lately considerably increased. Breast reconstruction itself can 
basically be classified into three categories, including (1) implant- 
and expander-based breast reconstruction, (2) flap-based breast 
reconstruction (vascularized autologous tissue), a combination of 
both (flap and implant), and (3) breast reconstruction using fat 
grafting (non-vascularized autologous lipoaspirate fat). However, 
fat grafting is predominantly used to refine post-reconstructive 
asymmetries. Nowadays, it is of importance that every woman 
having a high risk constellation (family history), being diagnosed 
with a genetic mutation and/or being affected with breast cancer 
gets the possibility to be presented to a multidisciplinary board of 
a certified breast center prior to surgery in order to be informed 
about all treatment modalities, including the various modalities of 
breast reconstruction. The goal of this multidisciplinary board is 
to best personalize breast reconstruction, of course putting to the 
fore the adequate oncological treatment. The patients also need 
to know the advantages and disadvantages of any reconstructive 
option, including the presumably less complex implant-based 
techniques that may result in high temporary satisfaction without 
any donor site morbidity and likelihood of reoperation due to 
capsular contracture and the clearly more complex flap-based 
techniques that will yield in high long-term satisfaction with the 
risk of donor site-associated complications.
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